tirzepatide weight loss nejm In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, was superior to semaglutide in reducing body and waist circumference. Full trial results and Research Summary SURMOUNT-1 (NEJM 2022) tested tirzepatide

A Strength of recommendation (SOR) A Good-quality patient-oriented evidence B Inconsistent or limited-quality patient-oriented evidence C Consensus, usual practice, opinion, disease-oriented evidence, case series The "Standards of Medical Care in Diabetes" guidelines published in 2015 by the American Diabetes Association (ADA) state that metformin is the preferred initial pharmacotherapy for managing type 2 diabetes

Additionally, it supports red blood cell formation and enhances overall energy levels

Energy-based treatments : Non-laser devices use technology like radiofrequency (RF) or ultrasound, applied topically to the skin, to send pulses below the skins surface to relax cellulite-causing bands and increase collagen production

BOOK YOUR APPOINTMENT Ready to achieve a refreshed you